Shopping Cart 0
Cart Subtotal
AED 0

Endonovo Therapeutics Inc (ENDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 0

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 0

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 0

Details

Summary

Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company's products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. Endonovo Therapeutics' pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders such as acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The company's Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.

Endonovo Therapeutics Inc (ENDV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11

Venture Financing 12

Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12

Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13

Endonovo Therapeutics Raises USD0.1 Million in Financing 14

Endonovo Therapeutics Raises Funds through Financing 15

Equity Offering 16

Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16

Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18

Debt Offering 19

Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19

Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20

Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21

Endonovo Therapeutics Inc-Key Competitors 22

Endonovo Therapeutics Inc-Key Employees 23

Endonovo Therapeutics Inc-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Strategy And Business Planning 25

Jan 16, 2018: Endonovo Therapeutics Provides Corporate Update and 2018 Outlook 25

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Endonovo Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11

Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12

Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13

Endonovo Therapeutics Raises USD0.1 Million in Financing 14

Endonovo Therapeutics Raises Funds through Financing 15

Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16

Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18

Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19

Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20

Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21

Endonovo Therapeutics Inc, Key Competitors 22

Endonovo Therapeutics Inc, Key Employees 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Endonovo Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company's products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. Endonovo Therapeutics' pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders such as acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The company's Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.

Endonovo Therapeutics Inc (ENDV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11

Venture Financing 12

Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12

Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13

Endonovo Therapeutics Raises USD0.1 Million in Financing 14

Endonovo Therapeutics Raises Funds through Financing 15

Equity Offering 16

Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16

Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18

Debt Offering 19

Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19

Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20

Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21

Endonovo Therapeutics Inc-Key Competitors 22

Endonovo Therapeutics Inc-Key Employees 23

Endonovo Therapeutics Inc-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Strategy And Business Planning 25

Jan 16, 2018: Endonovo Therapeutics Provides Corporate Update and 2018 Outlook 25

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Endonovo Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11

Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12

Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13

Endonovo Therapeutics Raises USD0.1 Million in Financing 14

Endonovo Therapeutics Raises Funds through Financing 15

Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16

Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18

Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19

Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20

Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21

Endonovo Therapeutics Inc, Key Competitors 22

Endonovo Therapeutics Inc, Key Employees 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Endonovo Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.